|
US2021118524A1
|
|
Identifying Therapeutic Targets by Discovering Interactions between Non-Coding Variants and Candidate Genes
|
|
WO2020210642A1
|
|
Methods and compositions for treating urea cycle disorders
|
|
WO2020081329A1
|
|
Methods and compositions for modulating pcsk9 and angptl3 expression
|
|
WO2020037069A1
|
|
Methods of treating liver diseases
|
|
WO2019195854A1
|
|
Compositions and methods for treating phenylketonuria
|
|
CN111971063A
|
|
Treatment of diseases by targeted modulation of gene signaling networks
|
|
CA3094481A1
|
|
Phenothiazine derivatives and uses thereof
|
|
CA3078247A1
|
|
Methods and compositions for treating urea cycle disorders, in particular otc deficiency
|
|
EP3668993A1
|
|
Methods of treating liver diseases
|
|
WO2018204764A1
|
|
Identification and targeted modulation of gene signaling networks
|
|
WO2018204762A1
|
|
Methods and compositions of modeling diseases with hematopoietic cell systems
|
